key: cord-0747523-kk9tahrp
authors: Raturi, Manish; Kusum, Anuradha
title: The Blood Supply Management amid the COVID-19 Outbreak
date: 2020-04-25
journal: Transfus Clin Biol
DOI: 10.1016/j.tracli.2020.04.002
sha: 836aedaa3d59f75b9b4e50e6c82ea90a3acacf07
doc_id: 747523
cord_uid: kk9tahrp

Abstract Due to the government’s early intervention such as mass lock-down and curtailment strategies towards mass gatherings, amid the COVID-19 outbreak, the organization of the voluntary blood donation camps have been suspended. It’s most significant impact on the blood community has been a dramatic reduction in the number of blood donors. Therefore, our blood stock has almost dried up and put our inventory in a state of jeopardy. Additionally, all the elective surgeries and non-urgent clinical interventions have also been deferred during this time. This has led to a drop in the blood collection, demand as well as the issue at our blood center. With this background, we intended to assess the effect of this lock-down on our blood supply management particularly in two phases [phase-I prior to outbreak] and phase-II [during the outbreak]. Transitioning back to normal conditions would most likely depend on the extent and the time duration of this pandemic and associated behavioural change, which is anticipated to remain in effect well beyond the original estimates.

The corona-virus disease-2019 caused by the novel coronavirus [nCoV] also known as "SARS-CoV-2" is a declared pandemic. This is primarily transmitted by the respiratory route [1] . Although WHO noted in 2003 that no cases of SARS-CoV had been reported due to transfusion of blood products, the transfusion transmission risk of this novel virus despite being theoretical, cannot be ignored at this juncture [2] . The outbreak of this nCoV has had a hugely negative impact on the blood community by decreasing the number of donations, thereby, affecting the blood transfusion services [BTS] worldwide [3, 4] . Therefore, all the BTS must assess, plan, and respond in a timely yet proportionate manner towards the upsurge of this devastating nCoV that has killed thousands globally till date. Blood community in these harrowing times must balance the procurement and the issuing of blood in a rather pro-active manner. The global recommendations of "social distancing" are being seen as the only effective measure to mitigate the community spread of this deadly pathogen. In the context of BTS, today's mandate to "flatten the curve of this pandemic" raises many questions that may transform its basic functioning. Few questions it raises are namely, how can we "ensure sufficient blood donations" within the existing limitations of social distancing? How should we protect our BTS staffs who are obligated to work in close proximity to the apparently healthy blood donors? How do we plan the duty-hours of our BTS staff in the wake of this pandemic when fear and anxiety are genuine among the healthcare workers? What could be the short and long-term implications of the reduced collections on our services? The answers to these questions will depend on the extent and time-duration of this pandemic and associated behavioural change, which is anticipated to remain in effect well beyond the original estimates.

Additionally, according to the recent advisory, by the government, all the voluntary blood donation camps [VBDCs] have been put on a hold as a part of the "curtailment strategy" to avoid mass gatherings [5] . With this background, we aimed to study the pattern of blood collection, its demand and issue both before and during this outbreak. We also intended to derive crucial lessons towards blood-supply management both for now as well as in future.

This was a retrospective descriptive study of six months [Oct'19 to Mar'20] data of a blood centre supporting a 1200 bedded multi-specialty tertiary care academic hospital in the Dehradun district of North India. The study was divided into two phases namely: 

The total whole blood [WB] collections in phase-I and phase-II were 88% [n=4420/5020] and 12%

[n=600/5020] respectively. In phase-I, we conducted twenty-two VBDCs as against seven in phase-II [ fig.1 ].

In phase-I, the average in-house [ 

It is a well-known fact that apart from donations, there is no other way to maintain sufficient bloodstock in the inventory. The emergence of COVID-19 has led to an enormous anxiety among blood donors and therefore, the blood community has been affected adversely. Having disrupted so many processes world-wide, the BTS are no exception. Therefore, it merited a compelling and justifiable review of our blood collection, The government's restrictions on conducting VBDCs as a part of the curtailment strategy has directly influenced the blood supply chain. To avoid shortage in these difficult times, in accordance to the national blood transfusion council, we are issuing an appointment letter for the voluntary blood donors, encouraging them to come to our blood centre individually during the lock-down period. Although prepared, till date we have not had any COVID-19 positive patients admitted in our hospital. Therefore, an increase in blood to address specific needs due to either inflammation or DIC [which is shown to happen in such COVID-19

positive cases] could not be evaluated at our facility. Furthermore, we have routinely been involved in the blood donor screening program that is able to prevent any individuals with active respiratory symptoms from donating blood. Additionally, the safety of both the donor as well as the BTS staff remains our priority during this time. An experience during the SARS epidemic [2002 to 2003] has shown that the most significant impact on the blood supply during a pandemic is likely to be a dramatic reduction in blood donors [9] . Similarly, a significant 64% drop in the frequency of IH blood donations from pre-pandemic to the full-blown pandemic phase has been observed at our facility.

Literature suggests that influenza and its complications are generally not associated with the need for blood transfusions, and an increased need for blood components during a pandemic is highly unlikely. Conversely, there may be a decrease in the blood demand as healthcare capacity is shifted towards providing the basic healthcare support, and non-urgent clinical interventions are usually deferred. It is estimated that demand for red cells will decrease by 5 to 25%, and frozen and fractionated products by 0-10%, with little or no change in platelet demands [10] . In our study, we noted that due to the deferral of elective surgeries and routine procedures during phase-II, there was a reduction in both the demand as well as the issue of blood units. A blood component wise reduction in the demand was 14%, 11% and 1.6% for PRBC, fresh frozen plasma and platelets respectively. Likewise, we noticed a reduction in the PRBC issued during the phase-II as 17% as against 83% in phase-I

Knowledge of the COVID-19 is evolving every day. An effective communication strategy with the voluntary blood donors to motivate them for donations and networking with the nearby blood establishments will help go a long way in the blood supply management during this pandemic. 

Interim Guidance on COVID-19

World Health Organization. WHO recommendations on SARS and blood safety

Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing

Blood supply management during an influenza pandemic

Pattern of blood procurement, ordering and utilization in a University Hospital in Eastern Saudi Arabia

The progress of South Korean blood transfusion services

Transfusion of older stored blood and risk of death: a meta-analysis

European Blood Alliance: Pandemic Influenza -Planning for Blood Organisations. European Blood Alliance

WHO Guidelines for National Blood Transfusion Services: Maintaining a Safe and Adequate Blood Supply in the Event of Pandemic Influenza. Geneva, World Health Organization